Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy.

Podobne knjige/članki

• Erratum: Evaluation of molecular forms of PSA and human kallikrein 2 in predicting biochemical failure following radical prostatectomy (International Journal of Cancer (2009) 125 (659-663) DOI:10.1002/ijc.23983)
  od: Wenske, S, et al.
  Izdano: (2010)
• Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
  od: Steuber, T, et al.
  Izdano: (2006)
• Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.
  od: O'Brien, M, et al.
  Izdano: (2009)
• Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.
  od: Stephenson, A, et al.
  Izdano: (2006)
• Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
  od: Steuber, T, et al.
  Izdano: (2007)